生理性术前膝关节过伸是前交叉韧带翻修队列中失败的一个预测因素:来自MARS组的报告
该队列研究前瞻性纳入2006至2011年间接受单束移植物前交叉韧带翻修重建的患者,2年随访率91%,共分析1145例。术前被动膝关节过伸≥5°见于374例(33%),过伸≥5°组移植物失败率为3.2%,非过伸组为2.9%;回归模型中年轻年龄、使用异体移植物和过伸≥5°是移植物失败的显著预测因素。
要点
- 翻修前交叉韧带重建患者中,术前被动膝关节过伸≥5°的患病率为33%。
- 过伸≥5°组2年移植物失败率为3.2%,非过伸组为2.9%。
- 过伸≥5°是移植物失败的独立显著预测因素,OR=2.12(95%CI 1.1-4.7;P=0.03)。
核心结论
- 术前生理性被动膝关节过伸≥5°见于三分之一接受翻修前交叉韧带重建的患者。
- 过伸≥5°是翻修前交叉韧带重建后移植物失败的独立显著预测因素,后续移植物断裂的OR超过2倍。
研究设计与样本
- 队列研究,证据等级2级。
- 患者于2006年至2011年间被识别并前瞻性入组,纳入标准为接受单束移植物重建的患者。
- 在2年时进行随访,要求患者完成相同的结局工具(国际膝关节文献委员会评分、膝关节损伤和骨关节炎结局评分、WOMAC和Marx活动评定量表)并提供翻修前交叉韧带移植物失败的信息。
- 以移植物失败为因变量的回归模型纳入年龄、性别、翻修前交叉韧带手术时的移植物类型以及术前生理性被动过伸≥5°(是/否),以评估这些因素作为翻修前交叉韧带重建后2年临床结局的潜在危险因素。
- 分析纳入1145例患者,其中91%获得2年随访;中位年龄26岁(年龄为连续变量),低于中位数为「较年轻」组,高于中位数为「较年长」组(年龄:四分位距=20,35岁),42%为女性;移植物类型为自体移植物50%、异体移植物48%、自体加异体组合2%。
主要发现
- 翻修队列中374例(33%)存在被动膝关节过伸≥5°,其中52%为女性。
- 整个队列2年随访时发生移植物断裂34例,其中过伸≥5°组12例(失败率3.2%),非过伸组22例(失败率2.9%)。
- 失败患者的中位年龄为19岁,而移植物完整者为26岁。
- 回归模型中三个变量是移植物失败的显著预测因素:较年轻年龄(OR=3.6;95%CI 1.6-7.9;P=0.002)、使用异体移植物(OR=3.3;95%CI 1.5-7.4;P=0.003)和过伸≥5°(OR=2.12;95%CI 1.1-4.7;P=0.03)。
关键数值与推荐
- 术前生理性被动膝关节过伸≥5°定义为过伸组,其移植物失败OR=2.12(95%CI 1.1-4.7;P=0.03)。
- 较年轻年龄(低于中位年龄26岁)的移植物失败OR=3.6(95%CI 1.6-7.9;P=0.002)。
- 使用异体移植物的移植物失败OR=3.3(95%CI 1.5-7.4;P=0.003)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The occurrence of physiologic knee hyperextension (HE) in the revision anterior cruciate ligament reconstruction (ACLR) population and its effect on outcomes have yet to be reported. Hypothesis/Purpose: The prevalence of knee HE in revision ACLR and its effect on 2-year outcome were studied with the hypothesis that preoperative physiologic knee HE ≥5° is a risk factor for anterior cruciate ligament (ACL) graft rupture. STUDY DESIGN: Cohort study; Level of evidence, 2. METHODS: Patients undergoing revision ACLR were identified and prospectively enrolled between 2006 and 2011. Study inclusion criteria were patients undergoing single-bundle graft reconstructions. Patients were followed up at 2 years and asked to complete an identical set of outcome instruments (International Knee Documentation Committee, Knee injury and Osteoarthritis Outcome Score, WOMAC, and Marx Activity Rating Scale) as well as provide information regarding revision ACL graft failure. A regression model with graft failure as the dependent variable included age, sex, graft type at the time of the revision ACL surgery, and physiologic preoperative passive HE ≥5° (yes/no) to assess these as potential risk factors for clinical outcomes 2 years after revision ACLR. RESULTS: Analyses included 1145 patients, for whom 2-year follow-up was attained for 91%. The median age was 26 years, with age being a continuous variable. Those below the median were grouped as "younger" and those above as "older" (age: interquartile range = 20, 35 years), and 42% of patients were female. There were 50% autografts, 48% allografts, and 2% that had a combination of autograft plus allograft. Passive knee HE ≥5° was present in 374 (33%) patients in the revision cohort, with 52% being female. Graft rupture at 2-year follow-up occurred in 34 cases in the entire cohort, of which 12 were in the HE ≥5° group (3.2% failure rate) and 22 in the non-HE group (2.9% failure rate). The median age of patients who failed was 19 years, as opposed to 26 years for those with intact grafts. Three variables in the regression model were significant predictors of graft failure: younger age (odds ratio [OR] = 3.6; 95% CI, 1.6-7.9; P = .002), use of allograft (OR = 3.3; 95% CI, 1.5-7.4; P = .003), and HE ≥5° (OR = 2.12; 95% CI, 1.1-4.7; P = .03). CONCLUSION: This study revealed that preoperative physiologic passive knee HE ≥5° is present in one-third of patients who undergo revision ACLR. HE ≥5° was an independent significant predictor of graft failure after revision ACLR with a >2-fold OR of subsequent graft rupture in revision ACL surgery. Registration: NCT00625885 ( ClinicalTrials.gov identifier).
引用
- Cooper DE, Dunn WR, Huston LJ, et al. Physiologic Preoperative Knee Hyperextension Is a Predictor of Failure in an Anterior Cruciate Ligament Revision Cohort: A Report From the MARS Group. Am J Sports Med. 2018. PMID: 29882693. doi:10.1177/0363546518777732
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。